Arkolith/Insider Trading/ENVB/Form 4

Hagel Jillian Marie

Chief Technology OfficerEnveric Biosciences, Inc. (ENVB) · full profile →Form 4 · filed Oct 18, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 16, 2021Grant(A)82K——82K
Sep 16, 2021Grant(A)532K——532K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 16, 2021Grant(A)100K——100K
Sep 16, 2021Grant(A)1K——1K
Sep 16, 2021Grant(A)532K——532K
Sep 16, 2021Grant(A)80K——80K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-025638) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML